Revenue

6 Months Ended

Jun. 30, 2023

Revenue Recognition [Abstract]

Revenue

4. Revenue

Net sales by geography are as follows (in millions):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
United States	$	1,068.9	$	1,017.6	$	2,129.2	$	1,958.8
International		800.7		764.2		1,571.4		1,486.2
Total	$	1,869.6	$	1,781.8	$	3,700.6	$	3,445.0

Net sales by product category are as follows (in millions):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Knees	$	771.4	$	704.9	$	1,533.9	$	1,367.7
Hips		504.3		487.2		997.1		938.2
S.E.T.		442.7		446.4		876.1		863.2
Other		151.2		143.3		293.5		275.9
Total	$	1,869.6	$	1,781.8	$	3,700.6	$	3,445.0

S.E.T. includes sales from our Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic ("CMFT") product categories. Other includes sales from our Technology, Surgical and Bone Cement product categories.

This net sales presentation differs from our reportable operating segments, which are based upon our senior management organizational structure and how we allocate resources toward achieving operating profit goals. Each of our reportable operating

segments sells all the product categories noted above. Accordingly, the only difference from the presentation above and our reportable operating segments are the geographic groupings.